Biosysen Limited (HKG:1355)
Hong Kong · Delayed Price · Currency is HKD 0.1380
+0.0080 (6.15%)
Jun 18, 2026, 3:20 PM HKT
Biosysen Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -43.53 | -21.12 | -38.18 | -7.79 | 4.98 |
Depreciation & Amortization | 13.72 | 24.03 | 29.16 | 30.65 | 30.11 |
Loss (Gain) From Sale of Assets | 0.11 | - | - | - | - |
Asset Writedown & Restructuring Costs | 10.25 | 30.82 | 41.76 | - | 0.01 |
Loss (Gain) From Sale of Investments | - | 2.01 | 1.86 | -1.42 | -2.75 |
Provision & Write-off of Bad Debts | 1.49 | -13.71 | 14.57 | 0.21 | - |
Other Operating Activities | 0.78 | -10.33 | -17.79 | -4.01 | -0.75 |
Change in Accounts Receivable | -20.89 | 14.54 | 3.04 | -12.23 | -7.15 |
Change in Inventory | 0.05 | -0.03 | -0.04 | 0.01 | -0.26 |
Change in Accounts Payable | 3.32 | -1.94 | - | 4.38 | 5.29 |
Change in Other Net Operating Assets | 2.01 | - | 0.77 | -0.44 | 0.91 |
Operating Cash Flow | -32.69 | 24.27 | 35.16 | 9.35 | 30.4 |
Operating Cash Flow Growth | - | -30.98% | 276.12% | -69.25% | 51.68% |
Capital Expenditures | -16.92 | -0.26 | -0.65 | -2.94 | -16.34 |
Sale of Property, Plant & Equipment | 0.1 | - | - | - | - |
Cash Acquisitions | -15 | - | - | - | - |
Other Investing Activities | 0 | 0.01 | 0 | 0.01 | 0.03 |
Investing Cash Flow | -31.81 | -0.25 | -0.64 | -2.93 | -16.31 |
Short-Term Debt Issued | 17.17 | 1.1 | - | 4.7 | 17.87 |
Total Debt Issued | 17.17 | 1.1 | - | 4.7 | 17.87 |
Short-Term Debt Repaid | - | -10.17 | -12.68 | -0.33 | -14.48 |
Long-Term Debt Repaid | -15.64 | -17.89 | -22.26 | -23.38 | -23.2 |
Total Debt Repaid | -15.64 | -28.07 | -34.94 | -23.71 | -37.68 |
Net Debt Issued (Repaid) | 1.54 | -26.97 | -34.94 | -19.01 | -19.81 |
Issuance of Common Stock | 51.45 | 14.99 | - | - | - |
Financing Cash Flow | 52.99 | -11.98 | -34.94 | -19.01 | -19.81 |
Foreign Exchange Rate Adjustments | 0.11 | -0.4 | 0.21 | 0.73 | 0.05 |
Net Cash Flow | -11.41 | 11.64 | -0.22 | -11.86 | -5.67 |
Free Cash Flow | -49.61 | 24.01 | 34.51 | 6.41 | 14.06 |
Free Cash Flow Growth | - | -30.42% | 438.41% | -54.41% | - |
Free Cash Flow Margin | -96.69% | 59.02% | 51.01% | 10.17% | 19.92% |
Free Cash Flow Per Share | -0.05 | 0.04 | 0.08 | 0.01 | 0.03 |
Cash Income Tax Paid | 0.36 | 0.25 | 3.08 | 2.51 | 3.29 |
Levered Free Cash Flow | -34.23 | 11.14 | 22.46 | 7.96 | 30.41 |
Unlevered Free Cash Flow | -31.18 | 14.8 | 26.06 | 12.56 | 35.46 |
Change in Working Capital | -15.52 | 12.57 | 3.77 | -8.28 | -1.21 |